Dr. Al-Louzi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
127 S. San Vicente Blvd. A6600
Los Angeles, CA 90048Phone+1 310-423-6472Fax+1 844-342-0058
Summary
- Dr. Omar Al-Louzi is a neurologist based in Los Angeles, CA, with subspecialties in Neuroimmunology and Multiple Sclerosis. He obtained his medical degree from the University of Jordan Faculty of Medicine in 2013. His postgraduate training included an Internal Medicine internship at Salem Hospital, a Neurology residency at Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School, and a Neuroimmunology & Multiple Sclerosis fellowship at the National Institutes of Health Clinical Center. Dr. Al-Louzi has extensive experience dealing with conditions like multiple sclerosis, optic neuritis, cervical myelopathy, thoracic myelopathy, and neuroimmunology. Additionally, he is a published researcher, known for significant contributions to medical literature, particularly on multiple sclerosis. He is also involved in clinical trials named MS-ResearchBiomarkerS.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Neuroimmunology & Multiple Sclerosis, 2021
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2016 - 2019
- Salem HospitalInternship, Internal Medicine, 2015 - 2016
- University of Jordan Faculty of MedicineClass of 2013
Certifications & Licensure
- CA State Medical License 2020 - 2026
- MT State Medical License 2024 - 2026
- AZ State Medical License 2024 - 2025
- CO State Medical License 2024 - 2025
- NM State Medical License 2024 - 2025
- OR State Medical License 2024 - 2025
- WA State Medical License 2024 - 2025
- American Board of Psychiatry and Neurology Neurology
- Join now to see all
Clinical Trials
- MS-ResearchBiomarkerS Start of enrollment: 2021 Nov 11
Publications & Presentations
PubMed
- 21 citationsRetrograde trans-synaptic visual pathway degeneration in multiple sclerosis: A case series.Omar Al-Louzi, Julia Button, Scott D. Newsome, Peter A. Calabresi, Shiv Saidha
Multiple Sclerosis. 2017-04-07 - 13 citationsFrom pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions.Hadar Kolb, Omar Al-Louzi, Erin S Beck, Pascal Sati, Martina Absinta
Neuroimage. Clinical. 2022-01-01 - 22 citationsCortical lesions, central vein sign, and paramagnetic rim lesions in multiple sclerosis: Emerging machine learning techniques and future avenues.Francesco La Rosa, Maxence Wynen, Omar Al-Louzi, Erin S Beck, Till Huelnhagen
Neuroimage. Clinical. 2022-01-01
Authored Content
- Al-Louzi O., Burton L., Galetta K., Prust M., Bowley M. (2019). Neurology Chapter. In Sabatine, M. S. (2019) Pocket medicine (Seventh Edition).August 2019
- Al-Louzi O., Saidha S. Pathophysiology of Optic Neuritis. In: Multiple Sclerosis: A Mechanistic View.May 2016
Press Mentions
- What Diseases Mimic MS (Multiple Sclerosis)?February 23rd, 2023
- Getting the Diagnosis Right with Multiple SclerosisJune 8th, 2022
- April Research HighlightsApril 29th, 2022
- Join now to see all
Grant Support
- Clinician-Scientist Development Award in Multiple SclerosisNational MS Society and American Brain FoundationPresent
Other Languages
- Arabic
External Links
- Patient Ratings & Commentshttps://www.cedars-sinai.org/provider/omar-allouzi-3650273.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: